|
Epilepsy Phenotype Case and Control |
Epilepsy/Antiepileptic drug response algorithm |
KPWHRI |
Case, Control |
23 |
3,282 |
|
|
|
NAFLD Implementation_Columbia |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
Columbia University |
Case, Control |
24 |
4,371 |
|
|
|
Implementation For Phase 3 eMERGE |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Geisinger |
Case, Control |
25 |
25 |
100%, 96% |
|
|
Group Health/University of Washington CRC Validation |
Colorectal Cancer (CRC) |
GH/UW |
Case, Control |
25 |
25 |
92%, 100% |
100%, 100% |
|
Marshfield AAA implementation |
Abdominal Aortic Aneurysm ( AAA ) |
Marshfield Clinic Research Foundation |
Case, Control |
25 |
22 |
100%, 100% |
|
|
Marshfield ACE-I cough implentation |
ACE Inhibitor (ACE-I) induced cough |
Marshfield Clinic Research Foundation |
Case, Control |
25 |
25 |
100%, 96% |
|
|
Geisinger Impl |
Colorectal Cancer (CRC) |
Geisinger |
Case, Control |
25 |
25 |
100%, 100% |
|
|
Intellectual disability Adult population |
Intellectual Disability |
Vanderbilt |
Case, Control |
25 |
6,231 |
|
|
|
Marshfield Hearing loss validation |
Hearing Loss |
Marshfield Clinic Research Foundation |
Case, Control |
25 |
25 |
100%, 100% |
|
|
Group Health and UW Zoster Implementation |
Herpes Zoster |
Group Health and UW |
Case, Control |
25 |
25 |
100%, 96% |
100% |
|
Geisinger Zoster Implementation |
Herpes Zoster |
Geisinger |
Case, Control |
27 |
27 |
89%, 96% |
100% |
|
Emerge III Implementation |
Appendicitis |
Geisinger |
Case, Control |
30 |
13,032 |
|
|
|
NU appendicitis cases |
Appendicitis |
Northwestern University |
Case Only |
30 |
|
100% |
|
|
Columbia - Migraine |
Migraine |
Columbia University Medical Center |
Case, Control |
37 |
2,294 |
|
|
|
Migraine--Columbia |
Migraine |
Columbia University |
Case, Control |
37 |
2,294 |
|
|
|
Statin and MACE Implementation - Columbia |
Statins and MACE |
Columbia University |
Case, Control |
41 |
570 |
|
|
|
Northwestern Univ. CAAD |
CAAD (Carotid Artery Atherosclerosis Disease) |
Northwestern University |
Case, Control |
44 |
461 |
|
|
|
Hypothyroidism Implementation - Columbia |
Hypothyroidism |
Columbia University |
Case, Control |
45 |
129 |
|
|
|
Harvard CDiff |
Clostridium Difficile Colitis |
Harvard Medical School |
Case Only |
47 |
1,643 |
|
|
|
Nortwestern University e3 Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Northwestern University |
Case, Control |
48 |
133 |
|
|
|
Marshfield diverticulosis/diverticulitis implementation |
Diverticulosis and Diverticulitis |
Marshfield Clinic Research Foundation |
Case, Control |
50 |
50 |
100%, 100% |
|
|
Northwestern University Validation |
Colorectal Cancer (CRC) |
Northwestern University |
Case, Control |
50 |
50 |
86%, 98% |
92% |
|
Autism Validation |
Autism |
CHOP |
Case Only |
50 |
|
85% |
74% |
|
Marshfield Venous Thromboembolism implementation |
Venous Thromboembolism (VTE) |
Marshfield Clinic Research Foundation |
Case, Control |
50 |
49 |
98%, 100% |
|
|
AMI/1st AMI Vanderbilt Implementation |
Statins and MACE |
Vanderbilt University |
Case Only |
50 |
|
96% |
|
